Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Solesence (SLSN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to 5.35%.

  • Solesence's EBITDA Margin fell 243100.0% to 5.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.87%, marking a year-over-year decrease of 53700.0%. This contributed to the annual value of 9.8% for FY2024, which is 193100.0% up from last year.
  • Solesence's EBITDA Margin amounted to 5.35% in Q3 2025, which was down 243100.0% from 9.38% recorded in Q2 2025.
  • Solesence's 5-year EBITDA Margin high stood at 18.96% for Q3 2024, and its period low was 23.68% during Q4 2023.
  • For the 5-year period, Solesence's EBITDA Margin averaged around 0.26%, with its median value being 1.29% (2022).
  • In the last 5 years, Solesence's EBITDA Margin skyrocketed by 343200bps in 2024 and then plummeted by -243100bps in 2025.
  • Quarter analysis of 5 years shows Solesence's EBITDA Margin stood at 4.06% in 2021, then crashed by -452bps to 22.42% in 2022, then fell by -6bps to 23.68% in 2023, then surged by 93bps to 1.77% in 2024, then tumbled by -202bps to 5.35% in 2025.
  • Its last three reported values are 5.35% in Q3 2025, 9.38% for Q2 2025, and 1.75% during Q1 2025.